- Home
- MXF vs IMMP Comparison
MXF vs IMMP Comparison
Compare MXF & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXF
- IMMP
- Stock Information
- Founded
- MXF 1981
- IMMP 1987
- Country
- MXF Mexico
- IMMP Australia
- Employees
- MXF N/A
- IMMP N/A
- Industry
- MXF Trusts Except Educational Religious and Charitable
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- MXF Finance
- IMMP Health Care
- Exchange
- MXF Nasdaq
- IMMP Nasdaq
- Market Cap
- MXF 272.0M
- IMMP 251.8M
- IPO Year
- MXF N/A
- IMMP N/A
- Fundamental
- Price
- MXF $18.93
- IMMP $2.05
- Analyst Decision
- MXF
- IMMP Buy
- Analyst Count
- MXF 0
- IMMP 1
- Target Price
- MXF N/A
- IMMP $7.00
- AVG Volume (30 Days)
- MXF 27.4K
- IMMP 203.4K
- Earning Date
- MXF 01-01-0001
- IMMP 10-10-2025
- Dividend Yield
- MXF 4.70%
- IMMP N/A
- EPS Growth
- MXF N/A
- IMMP N/A
- EPS
- MXF N/A
- IMMP N/A
- Revenue
- MXF N/A
- IMMP $3,306,742.00
- Revenue This Year
- MXF N/A
- IMMP $16.82
- Revenue Next Year
- MXF N/A
- IMMP N/A
- P/E Ratio
- MXF N/A
- IMMP N/A
- Revenue Growth
- MXF N/A
- IMMP 31.28
- 52 Week Low
- MXF $14.77
- IMMP $1.32
- 52 Week High
- MXF $19.49
- IMMP $2.71
- Technical
- Relative Strength Index (RSI)
- MXF 59.35
- IMMP 54.24
- Support Level
- MXF $18.30
- IMMP $1.96
- Resistance Level
- MXF $19.40
- IMMP $2.17
- Average True Range (ATR)
- MXF 0.39
- IMMP 0.11
- MACD
- MXF 0.01
- IMMP -0.01
- Stochastic Oscillator
- MXF 97.27
- IMMP 19.44
About MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.